International Journal of Scientific and Research Publications

About Us
Editorial Board

Online Publication

Log In
New User?
       Register Now!
Forgot Password?
       Email Password!

Call For Papers

Call for Research Paper


Online Submission
Paper Submission Guidelines
Online Publication Charge
Print Publication Charge
How to publish research paper
Publication Certificate
Research Catalogue


Join Reviewer Panel
Reviewer Guidelines


IJSRP Paper Format

Contact Us

Feedback Form
Contact Us
Site Map

IJSRP, Volume 7, Issue 6, June 2017 Edition [ISSN 2250-3153]

      Susmita Majumder, Sandip Pal, Dalia Mukhopadhyay

Abstract: Pancreatic cancer remains one of the deadliest cancers, which is usually diagnosed in an advanced state for which there are little or no effective therapies. In this perspective, efforts have been made to identify specific subset of cells that has the capability of producing differentiated progeny of cells. There are three major types of cancer stem cells (CSCs), but the most important type of CSCs nowadays are chemoreristant and radioresistant CSCs that are resistant from both - chemotherapy and radiotherapy. Hence, these chemoresistant and radioresistant CSCs were identified, which may provide some novel therapeutic approach to treat pancreatic cancer. Increased numbers of CD44+CD24+ESA+ cells were needed to generate tumors when injected into the pancreas. Identified CD44+CD24+ESA+ pancreatic CSCs showed the stem cell properties i.e. self-renewal, the ability to produce differentiated progeny. Several signaling pathways are upregulated in the pancreatic CSCs. Sonic Hedgehog (SHh) signaling molecule expression was very high in CD44+CD24+ESA+ cells compared to other normal pancreatic epithelial cells. Cyclopamine, a steroidal alkaloid, which has both teratogenic and antitumor activities, inhibited Hh signaling thereby inhibited pancreatic cancer growth in vitro and in vivo, suggesting that this signaling pathway has an early and critical role in the development of pancreatic cancer. Inhibition of Hh signaling by cyclopamine indicates that in the near future cyclopamine can be used as a drug to show that it can show some promise in the treatment of pancreatic cancer.

[Reference this Paper]   [BACK]

Ooops! It appears you don't have a PDF plugin for this barrPostingser. you can click here to download the PDF file.

Reference this Research Paper (copy & paste below code):

Susmita Majumder, Sandip Pal, Dalia Mukhopadhyay (2017); A systematic review on pancreatic cancer stem cells as a novel paradigm for curing pancreatic cancer; Int J Sci Res Publ 7(6) (ISSN: 2250-3153).



About Us
Editorial Board
Call for Paper

Call for Research Paper
Paper Status
IJSRP Paper Format
Join Us

Download e-journal
Join Forum
Invite Friends
Get Social with Us!

Copyright © 2011-2016, IJSRP Inc., All rights reserved.